Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • FROM THE ANALYST'S COUCH

The company landscape for artificial intelligence in large-molecule drug discovery

By
  1. Navraj S. Nagra

    1. McKinsey & Company, London, UK.

  2. Lieven van der Veken

    1. McKinsey & Company, Lyon, France.

  3. Erika Stanzl

    1. McKinsey & Company, Zürich, Switzerland.

  4. David Champagne

    1. McKinsey & Company, London, UK.

  5. Alex Devereson

    1. McKinsey & Company, London, UK.

  6. Matej Macak

    1. McKinsey & Company, London, UK.

Artificial intelligence (AI) techniques such as machine learning are transforming drug research and development (R&D), enabled by ever-increasing amounts of data and computational power. Historically, small molecules have been at the forefront of AI applications in drug discovery, including modelling small-molecule–target interactions, lead candidate optimization and safety prediction. However, AI tools are increasingly being applied to large-molecule modalities, including antibodies, gene therapies and RNA-based therapies. Such therapies represent an important share of the biopharma industry’s current portfolio — around 40% of new molecules approved in 2022 — and of its future commercial potential. For example, in oncology, large molecules are forecast to represent ~50% of the market by revenue in 2030, of which more than 80% is expected to be derived from antibodies.

Login or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account
Continue with Google
Continue with ORCiD

Nature Reviews Drug Discovery 22, 949-950 (2023)

doi: https://doi.org/10.1038/d41573-023-00139-0

Acknowledgements

The authors wish to thank Jeffrey Algazy, Joachim Bleys, Sam White, Ester Friedlaenderova, Thomas Devenyns, Rachel Moss, Michael Steinmann and Chris Anagnostopoulos for their contributions to this article.

Supplementary Information

  1. Supplementary information

Competing Interests

The authors of this article are employees of McKinsey & Company, a management consultancy that works with the world’s leading biopharmaceutical and biotechnology companies. The research for this specific article was funded by McKinsey’s Life Sciences practice.

Nature Careers

Jobs

  • Insect Neuroscientist

    Pioneer the development of insect-based biorobots—join SWARM Biotactics as an Insect Neuroscientist.

    Kassel, Hessen (DE)

    SWARM Biotactics

  • Director of The Roslin Institute

    The University is looking for an exceptional individual to work with our Principal Investigators, professional services staff and technical support

    Edinburgh - Easter Bush Campus, Midlothian, United Kingdom (100% On-campus)

    The Roslin Institute

  • PhD Candidate (m/f/d): Analysis of Microscopic BIOMedical Images (AMBIOM)

    A new project area in the institute is the development of artificial intelligence (AI)

    Dortmund, Nordrhein-Westfalen (DE)

    Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V.

  • Director, Pharmacometrics

    Biogen is seeking a Director, Pharmacometrics to provide guidance on and execute advanced modeling strategies

    Remote (US)

    Biogen

  • Medical Director, Clinical Development, Immunology

    Biogen is seeking a Medical Director for the Immunology Therapeutic Area within the Clinical Development Organization.

    Cambridge, Massachusetts (US)

    Biogen

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links